cas 165546-19-0|| where to buy 6-(1H-1,2,4-Triazol-1-yl)-9H-purine

Nom du produit:6-(1H-1,2,4-Triazol-1-yl)-9H-purine

IUPAC Name:6-(1H-1,2,4-triazol-1-yl)-9H-purine

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 165546-19-0 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:165546-19-0; Formule moléculaire:C7H5N7; Point de fusion:-; Code SMILES:C12=NC=NC(N3N=CN=C3)=C1N=CN2; Densité:

: Numéro de catalogue:CM230785; Poids moléculaire:187.17; Point d'ébullition:; N° Mdl:; Stockage:

: Purines; Purines are heterocyclic aromatic compounds composed of linked pyrimidine and imidazole rings. In mammals, purines are most commonly expressed in DNA and RNA (including the purines adenine and guanine), as well as single-molecule nucleotides (adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate (AMP), cyclic AMP, and to a lesser extent guanosine triphosphate (GTP) and cyclic guanosine monophosphate (cGMP). Purines are also key elements of the following energy metabolism molecules: reduced nicotinamide adenine dinucleotide, nicotinamide adenine dinucleotide phosphate (NADPH), and coenzyme Q. Purines can also act as direct neurotransmitters; for example, adenosine may interact with receptors to modulate cardiovascular and central nervous system (CNS) function.; purine wholesale; Find trusted purine wholesaler. Any requirements and problems can ask us at any time.

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.